Cyclacel Pharmaceuticals
- Pharmaceutical Preparations
- Berkeley Heights, New Jersey
Compensation history
Top executives at Cyclacel Pharmaceuticals received an average of $644K per person in annual compensation from 2006 to 2023.
By year
Executives
We found nine executives who work or worked at Cyclacel Pharmaceuticals.
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
Paul McBarron
Cyclacel Pharmaceuticals
Chief Financial Officer
Mark Kirschbaum
Cyclacel Pharmaceuticals
Chief Medical Officer
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
Robert Jackson
Cyclacel Pharmaceuticals
Chief Scientific Officer
Robert Kirkman
Cyclacel Pharmaceuticals
Chief Executive Officer
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2007 pay falls 27% to $1.3M
April 2, 2008
Cyclacel Pharmaceuticals CEO Spiro Rombotis receives $1.8M in 2006
April 5, 2007
About Cyclacel Pharmaceuticals
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922
- 908-517-7330
- December 31
- Former names
- XCYTE THERAPIES INC